ZhiShu Health Secures $2.5M in Angel Funding to Advance 3D-Printed Orthopedic Implants

PEdaily (ID: pedaily2012) reported on October 1 that, according toCYZONEReport: ZSFab Completes $2.5 Million Angel Round; Investors Undisclosed

ZSFab primarily designs products based on the needs of orthopedic device manufacturers, taking into account factors such as bone ingrowth, biomechanical compatibility, and safety. It utilizes algorithm-supported bio-titanium technology for product design and delivers the designs to orthopedic device manufacturers for production and processing. The orthopedic device manufacturers are responsible for clinical trials, regulatory submissions, sales, and other related tasks. Through this design platform, ZSFab has developed interbody fusion cages suitable for surgeries involving spinal regions such as the cervical and lumbar spine, as well as joint areas including the hip and knee joints.

ZSFab adopts a “SaaS platform + hardware products” marketing strategy, designing and developing orthopedic devices on one hand, and providing orthopedic device design services via its SaaS platform on the other.

ZSFab has currently completed Phase II animal trials. Following FDA approval, ZSFab will focus on serving medical device companies both domestically and internationally, enabling high-quality devices to benefit a broader patient population. Meanwhile, the company is pursuing further technological advancements to enhance rapid patient recovery.